Summary

Report Scope
Both qualitative and quantitative data on the current market dynamics and trends are presented in this report on the global market for needle-free devices. The report also assesses recent technological developments and product performance. Analyses of the most popular products, clinical trials, new product approvals, and emerging technologies are also included. The market prospects for five regions—North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA)—are discussed. The report also includes profiles of leading companies and their strategies.
The global market is segmented into the following product types: needle-free injectors, inhaler technologies, transdermal patch technologies and other novel technologies. By application, the market is segmented into vaccines, pain management, insulin delivery, pediatric injections and others. By end-user, the market is segmented into hospitals and clinics, homecare settings, and research and academic institutions. For market estimates, data has been provided for 2024 as the base year, with forecasts for 2025 through 2030.
Report Includes
- 49 data tables and 56 additional tables
- An overview of the global market for needle-free devices and technologies
- Analyses of global market trends with data from 2022 to 2025 and projected CAGRs through 2030
- Highlights of the current and future market potential and quantification of the market by product type, application, end user and region
- Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
- Insight into various needle-free technologies that are used in drug delivery and their application areas
- Discussion of government regulations that can affect the global needle-free devices market
- Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Company profiles of major players within the industry, including GSK plc., Novartis AG, Viatris Inc., and PharmaJet

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Macroeconomic Factors
Impact of U.S. Tariffs on the Pharmaceutical and Medical Device Industries
Population Demographics and Aging Populations
Healthcare Infrastructure and Spending
Regulatory and Policy Landscape
Technological Advances and Funding
Geopolitical Risks, Trade Wars, and Supply Chain Disruptions
Porter’s Five Forces Analysis
Potential for New Entrants (Moderate to High)
Bargaining Power of Suppliers (Low to Moderate)
Bargaining Power of Buyers (Moderate to High)
Threat of Substitute Products or Services (High)
Industry Level of Competitiveness (Moderate to High)
Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing Incidence of Needlestick Injuries
Preference for Painless Drug Delivery
Demand for Home Healthcare and Self-Administration
Market Restraints
Cost of Needle-Free Technology
Limitations of Large Volume and Intravenous Administration Systems
Market Opportunities
Product Innovation
Increased Investments in Healthcare in Emerging Markets
Chapter 4 Regulatory Landscape
Overview
Regulatory Scenario in the U.S.
Regulatory Scenario in Europe
Regulatory Scenario in Japan
Regulatory Scenario in China
FDA-Approved Inhalers
FDA-Approved Transdermal Patch
Chapter 5 Emerging Trends and Pipeline Analysis
Emerging Trends
Smart Patches
Smart Inhalers
Sonophoresis
3D-Printed Microarray Patches
Dissolving/Degradable Patches
Pipeline Analysis
Takeaways
Patent Analysis
Inhaler Technologies
Transdermal Patches
Needle-Free Injectors
Findings
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown by Product Type
Takeaways
Inhaler Technologies
Transdermal Patches
Needle-free Injectors
Other Novel Technologies
Market Breakdown by Application
Takeaways
Vaccines
Pain Management
Insulin Delivery
Pediatric Drug Delivery
Other Applications
Market Breakdown by End-User
Takeaways
Hospital and Clinics
Homecare Settings
Research and Academic Institutions
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Takeaways
Market Shares of Leading Companies
Strategic Analysis
Chapter 8 Sustainability in Needle-Free Devices: ESG Perspective
Overview
Environmental Sustainability
Social Responsibility
Governance Perspective
ESG Risk Ratings
Concluding Remarks from BCC Research
Chapter 9 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
AKRA DERMOJET
APTARGROUP INC.
ARX LLC.
ASTRAZENECA
AVAXZIPEN
CROSSJECT
ENDO INC.
GSK PLC.
HALOZYME INC.
MIKA MEDICAL CO.
NOVARTIS AG
NUGEN MEDICAL DEVICES
PHARMAJET
PRESSPART VERWALTUNGS GMBH
VIATRIS INC.
Emerging Start-ups/Market Disruptors